DK1861080T3 - Idebenon til behandling af muskeldystrofier - Google Patents

Idebenon til behandling af muskeldystrofier

Info

Publication number: DK1861080T3
Authority: DK; Denmark
Prior art keywords: idebenone; treatment; muscular dystrophies; treating; muscular dystrophy
Prior art date: 2005-03-21

Application number

DK06723554.9T

Other languages

English (en)

Inventor

Thomas Meier

Gunnar Buyse

Original Assignee

Santhera Pharmaceuticals Ch

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-21

Filing date

2006-03-20

Publication date

2010-09-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36572153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1861080(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-03-20 Application filed by Santhera Pharmaceuticals Ch filed Critical Santhera Pharmaceuticals Ch

2010-09-06 Application granted granted Critical

2010-09-06 Publication of DK1861080T3 publication Critical patent/DK1861080T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

DK06723554.9T 2005-03-21 2006-03-20 Idebenon til behandling af muskeldystrofier DK1861080T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05006137		2005-03-21
PCT/EP2006/002536 WO2006100017A1 (en)	2005-03-21	2006-03-20	Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies

Publications (1)

Publication Number	Publication Date
DK1861080T3 true DK1861080T3 (da)	2010-09-06

Family

ID=36572153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06723554.9T DK1861080T3 (da)	2005-03-21	2006-03-20	Idebenon til behandling af muskeldystrofier

Country Status (17)

Country	Link
US (1)	US7977388B2 (da)
EP (1)	EP1861080B1 (da)
JP (1)	JP4896123B2 (da)
AT (1)	ATE468849T1 (da)
AU (1)	AU2006226623B2 (da)
CA (1)	CA2602290C (da)
CY (1)	CY1110182T1 (da)
DE (1)	DE602006014514D1 (da)
DK (1)	DK1861080T3 (da)
ES (1)	ES2345353T3 (da)
MX (1)	MX2007011571A (da)
NZ (1)	NZ561235A (da)
PL (1)	PL1861080T3 (da)
PT (1)	PT1861080E (da)
SI (1)	SI1861080T1 (da)
WO (1)	WO2006100017A1 (da)
ZA (1)	ZA200707833B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2046348B1 (en)	2006-08-01	2015-07-22	Phrixus Pharmaceuticals, Incorporated	Use of poloxamer for the prevention and/or treatment of heart failure
EP1891946A1 (en) *	2006-08-14	2008-02-27	Santhera Pharmaceuticals (Schweiz) AG	Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
ES2436781T3 (es) *	2007-12-17	2014-01-07	The Regents Of The University Of Michigan	Composiciones y procedimientos de tratamiento y prevención de deficiencias de músculo esquelético
ATE529104T1 (de) *	2008-04-09	2011-11-15	Santhera Pharmaceuticals Ch	Idebenon zur behandlung von durch muskuläre dystrophie vermittelten atemwegserkrankungen
EP2246048A1 (en) *	2009-04-30	2010-11-03	Santhera Pharmaceuticals (Schweiz) AG	Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
HRP20161407T1 (hr)	2010-08-16	2016-12-02	Santhera Pharmaceuticals (Schweiz) Ag	Derivati benzokinona za liječenje mitohondrijskih bolesti oka
CN103086861B (zh) *	2012-11-12	2015-09-16	刘炜	羟癸基苯醌衍生物及其用途
US20230047313A1 (en) *	2019-12-16	2023-02-16	Children`S Medical Center Corporation	Treating heart disease in muscular dystrophy patients
EP4351545A1 (en)	2021-06-07	2024-04-17	Katholieke Universiteit Leuven	Idebenone in the treatment of drug resistant epilepsy
CN113827585B (zh) *	2021-10-27	2023-04-11	山东大学齐鲁医院	艾地苯在治疗肢带型肌营养不良2g型中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8562998A (en)	1997-08-12	1999-03-01	Takeda Chemical Industries Ltd.	Idebenone-containing preparation for percutaneous administration
JPH11116470A (ja)	1997-08-12	1999-04-27	Takeda Chem Ind Ltd	イデベノン含有経皮投与製剤
US20030013772A1 (en) *	2000-02-23	2003-01-16	Murphy Michael A.	Composition, synthesis and therapeutic applications of polyamines
CA2272971C (en) *	1998-10-29	2008-01-15	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Quinone derivatives for treating or preventing diseases associated with iron overload
US20040081961A1 (en) *	2001-05-04	2004-04-29	Delegeane Angelo M	Proteases
EP1618881A1 (en)	2004-07-20	2006-01-25	Santhera Pharmaceuticals (Schweiz) GmbH	Use of non-glucocorticoid steroids for the treatment of muscular dystrophy

2006
- 2006-03-20 MX MX2007011571A patent/MX2007011571A/es active IP Right Grant
- 2006-03-20 US US11/886,388 patent/US7977388B2/en not_active Expired - Fee Related
- 2006-03-20 DK DK06723554.9T patent/DK1861080T3/da active
- 2006-03-20 PT PT06723554T patent/PT1861080E/pt unknown
- 2006-03-20 AU AU2006226623A patent/AU2006226623B2/en not_active Ceased
- 2006-03-20 NZ NZ561235A patent/NZ561235A/en not_active IP Right Cessation
- 2006-03-20 DE DE602006014514T patent/DE602006014514D1/de active Active
- 2006-03-20 SI SI200630706T patent/SI1861080T1/sl unknown
- 2006-03-20 ES ES06723554T patent/ES2345353T3/es active Active
- 2006-03-20 JP JP2008502302A patent/JP4896123B2/ja not_active Expired - Fee Related
- 2006-03-20 PL PL06723554T patent/PL1861080T3/pl unknown
- 2006-03-20 EP EP06723554A patent/EP1861080B1/en not_active Not-in-force
- 2006-03-20 CA CA2602290A patent/CA2602290C/en not_active Expired - Fee Related
- 2006-03-20 AT AT06723554T patent/ATE468849T1/de active
- 2006-03-20 WO PCT/EP2006/002536 patent/WO2006100017A1/en not_active Ceased
2007
- 2007-09-13 ZA ZA200707833A patent/ZA200707833B/xx unknown
2010
- 2010-07-06 CY CY20101100628T patent/CY1110182T1/el unknown

Also Published As

Publication number	Publication date
EP1861080B1 (en)	2010-05-26
US20090012050A1 (en)	2009-01-08
MX2007011571A (es)	2007-12-06
NZ561235A (en)	2010-12-24
JP4896123B2 (ja)	2012-03-14
EP1861080A1 (en)	2007-12-05
CA2602290A1 (en)	2006-09-28
ZA200707833B (en)	2008-06-25
WO2006100017A1 (en)	2006-09-28
US7977388B2 (en)	2011-07-12
AU2006226623A1 (en)	2006-09-28
AU2006226623B2 (en)	2010-04-22
PT1861080E (pt)	2010-06-17
JP2008533182A (ja)	2008-08-21
SI1861080T1 (sl)	2010-08-31
CY1110182T1 (el)	2015-01-14
ATE468849T1 (de)	2010-06-15
ES2345353T3 (es)	2010-09-21
DE602006014514D1 (da)	2010-07-08
PL1861080T3 (pl)	2010-10-29
CA2602290C (en)	2012-01-17

Similar Documents

Publication	Publication Date	Title
CY1110182T1 (el)	2015-01-14	Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
IL232313A0 (en)	2014-06-30	Modulators of indoleamine 2,3-dioxygenase and methods of using the aforementioned
SI1978947T1 (sl)	2014-12-31	Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij
CL2012003026A1 (es)	2013-02-01	Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
EP1731113B8 (en)	2013-11-13	Medical treatment kit
IL196965A (en)	2015-10-29	Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure
EP1912650B8 (en)	2017-10-18	Use of flibanserin in the treatment of obesity
CL2008002353A1 (es)	2008-10-24	Compuestos derivados de 7h-indolo[2,1-a][2]benzazepina; composicion farmaceutica; y uso en el tratamiento de la hepatitis c.
CL2007002619A1 (es)	2008-04-18	Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
CL2007002671A1 (es)	2008-04-18	Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
ZA200711105B (en)	2009-08-26	Novel physiological substance nesfatin substance relevant thereto, and use of the substances
BRPI0720323A2 (pt)	2016-08-09	composto, método de tratamento, composição farmacêutica e uso do composto
CL2007002769A1 (es)	2008-07-04	Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
BRPI0913297A2 (pt)	2016-01-26	composição, farmacêutica, uso de uma composição, e, kit terapêutico.
IL201426A0 (en)	2010-05-31	Drug combination and its use in the treatment of muscle loss
BRPI0719997A2 (pt)	2014-03-18	Uso de epotilonas no tratamento de osteoporose e doenças relacionadas
WO2006060084A3 (en)	2006-07-20	Coadministration of tigecycline and digoxin
ZA200609007B (en)	2008-07-30	Medical plaster for application on the skin
EP1908467A4 (en)	2008-10-08	Herpesvirus-derived therapeutic agent for pain
WO2007012066A3 (en)	2007-06-07	TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF
HK1153406A (en)	2012-03-30	Piperlongumine and piperlongumine analogs for use in the treatment of cancer
GB0405405D0 (en)	2004-04-21	Assays and medical treatments
CL2007003284A1 (es)	2008-03-24	Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas.
GB0401792D0 (en)	2004-03-03	Medical treatment
GB0419703D0 (en)	2004-10-06	Medical treatment